SCHEMBL433381

SCHEMBL433381

COC(=O)c1ccc2c(c1)C1CCC2N1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ XDH P47989 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA14 Q9ULX7 1/20 0.42
▸ ALDH1A1 P00352 8/20 0.42
▸ KDM4E B2RXH2 6/20 0.42
▸ HPGD P15428 4/20 0.42
▸ ATM Q13315 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42
▸ HSD17B10 Q99714 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL353212 0.82 ALDH1A1 (0.41) CA12CA1CA2CA7XDH
SCHEMBL10247203 0.79 NPC1 (0.46) ALDH1A1KDM4ERAB9AMAPTSMN1; SMN2
SCHEMBL26227721 0.75 ALDH1A1 (0.39) CA12CA1CA2CA7XDH
SCHEMBL23112216 0.74 SMN1; SMN2 (0.41) CA12CA1CA2CA7CA9
SCHEMBL10215462 0.74 SLC6A2 (0.56) CA12CA1CA2CA7XDH
SCHEMBL11152269 0.74 SLC6A2 (0.56) CA12CA1CA2CA7XDH
SCHEMBL16961717 0.73 SLC6A2 (0.33) CA1CA2SLC6A2SLC6A4SLC6A3
SCHEMBL16962887 0.73 CHRNB2 (0.35) CA12CA1CA2CA9ALDH1A1
SCHEMBL18682115 0.72 CA1 (0.55) CA12CA1CA2CA7XDH
SCHEMBL18670723 0.72 CA1 (0.55) CA12CA1CA2CA7XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012012322-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-01-26 — — WO disclosed
Send feedback